| #574 |
Joanna Norström |
Medartis Ag |
3 |
| #574 |
Eva Rödel |
Intrexon |
3 |
| #574 |
Horst Prescher |
— |
3 |
| #574 |
Gilbert Weber |
Dsm Ip Assets B.V. |
3 |
| #574 |
Wolfgang Holzgreve |
Sequenom |
3 |
| #574 |
Hendrik Moorlag |
Hoffmann-La Roche |
3 |
| #574 |
Stefan Martin Stoeckli |
Dsm Ip Assets B.V. |
3 |
| #574 |
Damiet Josephina Petronella Cunera Koenders |
Dsm Ip Assets B.V. |
3 |
| #574 |
Min Kim |
Swatch |
3 |
| #574 |
Massimo Pignone |
Novartis Ag |
3 |
| #574 |
Axel Buss |
Dsm Ip Assets B.V. |
3 |
| #574 |
Doris Stingelin |
Novartis Ag |
3 |
| #574 |
Juana-Lucia Flores-Candia |
Dsm Ip Assets B.V. |
3 |
| #574 |
Rene Emmenegger |
Paion Uk Limited |
3 |
| #574 |
Oliver Rusch |
Develco Pharma Schweiz Ag |
3 |
| #574 |
Andrew George Gum |
Dsm Ip Assets B.V. |
3 |
| #574 |
Samuel Hintermann |
Sloan Kettering Institute For Cancer Research |
3 |
| #574 |
Pascale Oddou |
Novartis Ag |
3 |
| #574 |
Jessica Mann |
Novartis Ag |
3 |
| #574 |
Han Hong |
Agency For Science, Technology And Research |
3 |
| #574 |
Paulo Fernandes Gomes Dos Santos |
Novartis Ag |
3 |
| #574 |
Doris Roth |
Hoffmann-La Roche |
3 |
| #574 |
Selma Zahirovic |
Alstom Technology |
3 |
| #574 |
Reinhard Knothe |
Apple |
3 |
| #574 |
Patrik Meier |
Genentech |
3 |
| #574 |
Pierre De Meuron |
— |
3 |
| #574 |
Thomas Bohnacker |
University Of Basel |
3 |
| #574 |
Thomas Holbro |
Novartis Ag |
3 |
| #574 |
Patrick Fauchère |
Adobe |
3 |
| #574 |
Stephane FERRETTI |
Novartis Ag |
3 |
| #574 |
Jonathan Samuel Sander |
MIT |
3 |
| #574 |
Lukas Hofstetter |
Abb Schweiz Ag |
3 |
| #574 |
David Martinez-Martin |
University Of Basel |
3 |
| #574 |
Sascha Martin |
University Of Basel |
3 |
| #574 |
Farshad Ramazani |
Novartis Ag |
3 |
| #574 |
Berend Frenzel |
— |
3 |
| #574 |
Patricia Scandiucci De Freitas |
Rolic Technologies Ag |
3 |
| #574 |
Raphael BIGLER |
Genentech |
3 |
| #574 |
Jan Pflug |
Endress+Hauser Process Solutions Ag |
3 |
| #574 |
Hassan Javanbakh |
Hoffmann-La Roche |
3 |
| #574 |
Stefanie KIRCHEN |
Dsm Ip Assets B.V. |
3 |
| #574 |
Sam LINDGREN |
Novartis Ag |
3 |
| #574 |
Thomas Oestergaard Tange |
Evolva Sa |
3 |
| #574 |
Ivan Formentini |
Fundación Del Sector Püblico Estatal Centro Nacional De Investigaciones Oncológicas Carlos Ii |
3 |
| #574 |
Heiner Bieli |
Straumann Holding Ag |
3 |
| #574 |
Greta Vastakaite |
Hoffmann-La Roche |
3 |
| #574 |
Jérôme Charles Sarie |
Hoffmann-La Roche |
3 |
| #574 |
Markus Zwickl |
Ciba-Geigy |
3 |
| #574 |
Adrian Müller |
Ciba Specialty Chemicals |
3 |
| #574 |
Stephen Paboojian |
Novartis Ag |
3 |